Summary

In many developing countries, insulin can cost more than 50% of the average per capita annual income. As a result, for many who live in these countries, type 1 diabetes can be a death sentence. Diabetes organizations around the world are working together, however, to find ways to provide insulin to patients who need it but cannot easily obtain it.